ai-imaging
(3)
Howard Rosen
Howard Rosen is the CEO and co-founder of Evident Vascular, a San Jose medtech startup building an AI-powered intravascular ultrasound (IVUS) platform for peripheral and coronary interventions. A 30-year cardiovascular device veteran, he spent 21 years at Boston Scientific before helping guide Intact Vascular and its spinout Vesper Medical through acquisitions by Philips. He launched Evident out of stealth in 2023 with a $35 million Series A led by Vensana Capital and closed a Series B in 2025. He is known for a disciplined 'go slow to go fast' company-building philosophy.
Michael Deng
Michael Deng is the founder, Chairman, President, and CEO of ArcSoft, a Fremont, California-based computer vision and AI imaging company he started in 1994 with $150,000 from family and friends. Over three decades, he built ArcSoft into a global leader powering the cameras of Samsung, Huawei, Xiaomi, Sony, and dozens more, then pivoted to automotive AI vision - driver monitoring, ADAS, and in-cabin sensing. When ArcSoft listed on Shanghai's STAR Market in 2021, Deng became a billionaire with a stake valued at roughly $1.1 billion. Today he's steering the company into AI glasses, XR headsets, robotics, and AIGC creative tools.
Neda Razavi
Neda Razavi is the CEO and Chairwoman of the Board at iSono Health, a South San Francisco medtech company building the world's first wearable, automated, portable FDA-cleared 3D breast ultrasound system. With 25 years of experience launching 65 products across six global platforms and generating over $9 billion in cumulative revenue at companies including Abbott, Roche, Medtronic, and Natera, Razavi joined iSono Health as an early investor and advisor before taking the helm in November 2023 to lead commercialization of the ATUSA system — a 2-minute, hands-free breast imaging device that pairs robotics, AI, and cloud analytics to make early breast cancer detection accessible to OB/GYNs and primary care providers without requiring a trained sonographer.